BTT1023

DRUG2 trials

Sponsors

Biotie Therapies Corp., University of Birmingham

Conditions

Plaque PsoriasisPrimary Sclerosing Cholangitis

Phase 1

BTT1023 in Psoriasis

CompletedNCT00871598

Biotie Therapies Corp.Plaque Psoriasis

Start: 2009-03-31End: 2010-08-31Updated: 2010-11-16

Phase 2

A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis

CompletedNCT02239211

University of BirminghamPrimary Sclerosing Cholangitis

Start: 2015-09-08End: 2018-10-23Updated: 2019-05-03

Related Papers

Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial

Efficacy and Mechanism Evaluation2022-03-015 citations

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

BMJ Open2017-06-0131 citations